Research into whether drugs like ayahuasca can mitigate the effects of traumatic brain injury is in its infancy. Pro athletes like the Buffalo Bills’ Jordan Poyer are forging ahead anyway.

Brent Simpson is the first police officer known to have C.T.E. He showed signs of the disease in the last few years of his life.

Athletes, often thought of as durable and tough, are vulnerable to PTSD.

Post Trauma is a fresh horror game with all the design elements that made 1990 classics like the Silent Hill and Resident Evil franchises so popular. Its storyline has an interesting twist in that it captures the disorienting nature of post-traumatic stress disorder and the disjointed path of healing from it.

Funded by an $11.5 million NIH grant, the CREATE Center aims to improve PTSD therapies through responsible AI development, working closely with mental health professionals and survivors to ensure a human-centered approach.

After Shane Christie took his own life at the age of just 39, David Walsh looks at how so many former players are suffering alone with a condition that can’t be diagnosed until after their deaths.

A former rugby player who was forced to give up the sport after suffering repeated concussions has spoken about his struggle with his mental health.

Nick Stephen, 30, started playing rugby in York aged eight, but had to walk away from the game aged 25 after his 13th concussion in three seasons.

He said leaving the sport behind "felt like my whole life had caved in" and he began suffering with migraines, tinnitus, nausea and panic attacks, and was later diagnosed with post-concussion syndrome.

Clinical trials have found psychedelic drugs can be an effective treatment for some patients. Researchers hope federal approval will allow these treatments to move forward. 

Two members of Congress and a veteran call to keep momentum going.

After decades of underinvestment in new approaches to treating post-traumatic stress disorder and related conditions, the Department of Veterans Affairs is finally turning a corner. In late 2023, the VA announced its first investment in psychedelic research in more than 50 years, launching clinical trials of MDMA-assisted therapy for PTSD. Now, we must keep the momentum going.

Single-cell analyses revealed molecular profiles that can distinguish PTSD from depression, potentially leading to better drugs for this psychiatric disorder.